EUVIMEDEUVIMED entdecken
Crossref

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer

Tokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Takayuki Goto, Sadafumi Kawamura, Yasuhiro Hashimoto, Atsushi Takahashi, Takahiro Kimura, Ken-Ichi Tabata und 23 weitere

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-024-02681-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Tokiyoshi Tanegashima und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantHumansMaleAgedRetrospective StudiesPrognosisMiddle AgedAged, 80 and overJapanNeoplasm MetastasisAndrogen Receptor AntagonistsTaxoidsKaplan-Meier Estimate

Stichwörter der Autor:innen

De novo mCSPCJapanOverall survivalPropensity score matchingProstate cancerRisk factors

Substanzen

cabazitaxelAndrogen Receptor AntagonistsTaxoids

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.
  • Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. shiota.masaki.101@m.kyushu-u.ac.jp.
  • Department of Urology, Miyazaki University, Miyazaki, Japan.
  • Department of Urology, Niigata Cancer Center Hospital, Niigata, Japan.
  • Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
  • Department of Urology, Shizuoka General Hospital, Shizuoka, Japan.

Zitieren

APA

Tanegashima, T., Shiota, M., Terada, N., Saito, T., Yokomizo, A., Kohei, N., Goto, T., Kawamura, S., Hashimoto, Y., Takahashi, A., Kimura, T., Tabata, K. I., Tomida, R., Hashimoto, K., Sakurai, T., Shimazui, T., Sakamoto, S., Kamiyama, M., Tanaka, N., …, & Japanese Urological Oncology Group (2025). Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02681-2

Vancouver

Tanegashima T, Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, et al. Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-024-02681-2

BibTeX
@article{Tanegashima2025,
  author = {Tanegashima, Tokiyoshi and Shiota, Masaki and Terada, Naoki and Saito, Toshihiro and Yokomizo, Akira and Kohei, Naoki and Goto, Takayuki and Kawamura, Sadafumi and Hashimoto, Yasuhiro and Takahashi, Atsushi and Kimura, Takahiro and Tabata, Ken-Ichi and Tomida, Ryotaro and Hashimoto, Kohei and Sakurai, Toshihiko and Shimazui, Toru and Sakamoto, Shinichi and Kamiyama, Manabu and Tanaka, Nobumichi and Mitsuzuka, Koji and Kato, Takuma and Narita, Shintaro and Yasumoto, Hiroaki and Teraoka, Shogo and Kato, Masashi and Osawa, Takahiro and Nagumo, Yoshiyuki and Matsumoto, Hiroaki and Enokida, Hideki and Sugiyama, Takayuki and Kuroiwa, Kentaro and Kitamura, Hiroshi and Kamoto, Toshiyuki and Eto, Masatoshi and Japanese Urological Oncology Group, Japanese Urological Oncology Group},
  title = {Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-024-02681-2}
}
Kostenlos starten →